
Sign up to save your podcasts
Or


Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part One of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the latest treatment advances for MCL. With more treatments available than just a few years ago, Dr. Lampson shares how his conversations with his patients have changed, providing more hope after a diagnosis of MCL.
Be sure to tune into Part 2 launching on May 23, 2022, where Dr. Lampson will focus on the exciting possibilities of CAR T-cell therapy for MCL.
Mentioned on this episode:
Additional LLS Support Resources:
Support for this episode provided by Eli Lilly & Company.
The post Mantle Cell Lymphoma (MCL) Part One: Treatment Advances first appeared on The Bloodline with Blood Cancer United Podcast.
By Blood Cancer United4.9
4646 ratings
Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part One of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the latest treatment advances for MCL. With more treatments available than just a few years ago, Dr. Lampson shares how his conversations with his patients have changed, providing more hope after a diagnosis of MCL.
Be sure to tune into Part 2 launching on May 23, 2022, where Dr. Lampson will focus on the exciting possibilities of CAR T-cell therapy for MCL.
Mentioned on this episode:
Additional LLS Support Resources:
Support for this episode provided by Eli Lilly & Company.
The post Mantle Cell Lymphoma (MCL) Part One: Treatment Advances first appeared on The Bloodline with Blood Cancer United Podcast.

26,004 Listeners

14,637 Listeners

37,286 Listeners

12,126 Listeners

87,994 Listeners

113,488 Listeners

204 Listeners

5,146 Listeners

12 Listeners

4,842 Listeners

14,362 Listeners

6,578 Listeners

8,216 Listeners

6,450 Listeners

41,636 Listeners